骆驼刺正丁醇萃取部位中单体化合物的分离纯化及其对人宫颈癌HeLa细胞的影响研究
x

请在关注微信后,向客服人员索取文件

篇名: 骆驼刺正丁醇萃取部位中单体化合物的分离纯化及其对人宫颈癌HeLa细胞的影响研究
TITLE:
摘要: 目的:分离纯化骆驼刺正丁醇萃取部位中的单体化合物,并探讨其对人宫颈癌HeLa细胞增殖、迁移的影响。方法:采用硅胶柱、Sephadex LH-20凝胶色谱柱、制备型高效液相色谱等方法对骆驼刺正丁醇萃取部位进行分离纯化,根据理化性质和波谱(质谱、氢谱、碳谱等)数据分析、鉴定化合物结构。以人宫颈癌HeLa细胞为对象,以5-氟尿嘧啶(5-FU)为阳性对照,采用四甲基偶氮唑盐法检测经各化合物不同剂量(均为6.25、12.5、25、50、100、200 μg/mL)预处理后的细胞抑制率,并计算半数抑制浓度(IC50),以筛选活性单体;采用划痕实验考察上述活性单体(均为50 μg/mL)对HeLa细胞迁移能力的影响;采用金氏公式评价5-FU与上述活性单体分别联用[(3.125+6.25)、(6.25+12.5)、(12.5+25)、(25+50)μg/mL]的效果。结果:从骆驼刺正丁醇萃取物部位中共分离得到6个化合物,分别鉴定为紫铆素(Ⅰ)、3′,4′,7-三羟基异黄酮(Ⅱ)、对甲氧基苯乙酸(Ⅲ)、4-羟基苯乙酮(Ⅳ)、橙黄胡椒酰胺(Ⅴ)、原儿茶醛(Ⅵ)。与空白对照组比较,5-FU和各化合物(5-FU:6.25~200 μg/mL各剂量,化合物Ⅰ:12.5~200 μg/mL各剂量,化合物Ⅱ:25、50、200 μg/mL,化合物Ⅲ:6.25、100、200 μg/mL,化合物Ⅳ:50、100、200 μg/mL,化合物Ⅴ:12.5、25、200 μg/mL,化合物Ⅵ:6.25~200 μg/mL各剂量)均可显著升高细胞抑制率,且化合物Ⅰ、Ⅴ、Ⅵ的IC50值均显著降低(P<0.05或P<0.01),其中化合物Ⅰ、Ⅵ的IC50值相对较低。5-FU与化合物Ⅰ、Ⅵ组细胞的迁移距离均较空白对照组显著缩小(P<0.05或P<0.01);5-FU分别与化合物Ⅰ、Ⅵ联用后,对HeLa细胞的增殖具有相加或增强的协同抑制作用(增效指数均大于0.9)。结论:化合物Ⅰ~Ⅵ均为首次从骆驼刺属植物中分离得到,紫铆素和原儿茶醛是其正丁醇萃取部位的活性单体。这2种活性单体均可抑制人宫颈癌HeLa细胞的增殖和迁移,具有较强的体外细胞抑制作用,且与5-FU联用后的抑制作用强于两者分别单用。
ABSTRACT: OBJECTIVE: To separate and purify Alhagi sparsifolia n-butanol extract monomeric compounds, and to investigate its effects on the proliferation and metastasis of human cervical cancer HeLa cells. METHODS: The n-butanol extract was separated and purified by silica gel column, Sephadex LH-20 gel column and prep-HPLC. The structures of compounds were analyzed and identified according to physicochemical properties and spectrum (mass spectrum, hydrogen spectrum, carbon spectrum) data. Using human cervical cancer HeLa cells as objects, 5-FU as positive control, MTT assay was used to detect the inhibitory rate of HeLa cells pretreated with different doses of compounds (6.25, 12.5, 25, 50, 100, 200 μg/mL); IC50 was calculated to screen active monomers. Scratch test was used to investigate the effects of above active monomers (all 50 μg/mL) on the migration ability of HeLa cells. Kim’s formula was used to evaluate the effects of 5-FU separately combined with above active monomers [(3.125+6.25),(6.25+12.5),(12.5+25),(25+50)μg/mL]. RESULTS: Six compounds were isolated from the n-butanol extract part of A. sparsifolia and identified as butin (Ⅰ), 3′,4′,7-trihydroxyisoflavone (Ⅱ), p-methoxyphenylacetic acid (Ⅲ), 4-hydroxyacetophenone (Ⅳ), aurantiamide acetate (Ⅴ), protocatechualdehydea (Ⅵ). Compared with blank control group, 5-FU and each compound (5-FU:6.25-200 μg/mL, compound Ⅰ: 12.5-200 μg/mL; compound Ⅱ: 25, 50, 200  μg/mL; compound Ⅲ: 6.25, 100, 200 μg/mL; compound Ⅳ: 50, 100, 200 μg/mL; compound Ⅴ: 12.5, 25, 200 μg/mL; compound Ⅵ: 6.25-200 μg/mL) could significantly increase the cell inhibition rate. IC50 of compound Ⅰ, Ⅴ, Ⅵ were decreased significantly (P<0.05 or P<0.01), and those of compound Ⅰ and Ⅵ were lower relatively. The migration distance of cells in 5-FU and compound Ⅰ and Ⅵgroups were decreased significantly, compared with blank control group (P<0.05 or P<0.01). 5-FU separately combined with compound Ⅰ and Ⅵ showed additive and enhanced inhibitory effects on the proliferation of HeLa cells (synergistic index>0.9). CONCLUSIONS: Compounds Ⅰ-Ⅵ are isolated from Alhagi for the first time. Butin and protocatechualdehydea are active monomers of its n-butanol extract part. Above two monomers can inhibit the proliferation and migration of human cervical cancer Hela cells, with strong inhibitory effect in vitro, and stronger inhibitory effect combined with 5-FU than any compound alone.
期刊: 2019年第30卷第4期
作者: 刘雪松,马晓玲,石磊岭,阿勒腾图娅,张大鹏,李宁,魏鸿雁
AUTHORS: LIU Xuesong,MA Xiaoling,SHI Leiling,Aletengtuya,ZHANG Dapeng,LI Ning,WEI Hongyan
关键字: 骆驼刺;正丁醇萃取部位;单体化合物;抗肿瘤活性;增殖;迁移;联合用药;人宫颈癌Hela细胞
KEYWORDS: Alhagi sparsifolia; n-butanol extract part; Monomeric compounds; Antitumor activity; Proliferation; Migration; Drug combination; Human cervical cancer HeLa cells
阅读数: 249 次
本月下载数: 8 次

* 注:未经本站明确许可,任何网站不得非法盗链资源下载连接及抄袭本站原创内容资源!在此感谢您的支持与合作!